Open access
Sep 2026
Targeting IL-2 to inflamed tissues via oxidation-specific epitopes enables third-generation bispecific IL-2 therapeutics
Thomas Vazquez, Monica Cuevas-Martinez, Nicolas M. Billiald et al.
· bioRxiv · 0 citations